Evidence of in vivo generation of thrombin in patients with small-for-gestational-age fetuses and pre-eclampsia

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 11, Issue 6, 2002, Pages 362-367

  Chaiworapongsa, T ^a   Yoshimatsu, J ^a   Espinoza, J ^a   Kim, Y M ^a   Berman, S ^b   Edwin, S ^a   Yoon, B H ^c   Romero, R ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Seoul National University   (South Korea)

Author keywords

Coagulation; Pre eclampsia; Small for gestational age; Tat complexes

Indexed keywords

THROMBIN; THROMBIN ANTITHROMBIN COMPLEX; ANTITHROMBIN III; ANTITHROMBIN III PROTEASE COMPLEX; ANTITHROMBIN III-PROTEASE COMPLEX; PEPTIDE HYDROLASE;

ADOLESCENT; ADULT; ARTICLE; BIRTH WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; SMALL FOR DATE INFANT; STATISTICAL ANALYSIS; BIOSYNTHESIS; BLOOD; CROSS-SECTIONAL STUDY; FETUS DISEASE; NEWBORN; THROMBOSIS;

ADOLESCENT; ADULT; ANTITHROMBIN III; CROSS-SECTIONAL STUDIES; FEMALE; FETAL DISEASES; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; PEPTIDE HYDROLASES; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; THROMBIN; THROMBOSIS;

EID: 0036022642     PISSN: 14767058     EISSN: None     Source Type: Journal    
DOI: 10.1080/jmf.11.6.362.367     Document Type: Article

References (53)

1. Uteroplacental vascular pathology
2. Infarctions and intervillous thrombosis in placenta, and their association with intrauterine growth retardation
3. Placental thrombi and other vascular lesions. Classification, morphology, and clinical correlations
4. Intrauterine growth restriction in infants of less than thirty-two weeks' gestation: Associated placental pathologic features
5. Thrombophilia: A mechanism of disease in women with adverse pregnancy outcome and thrombotic lesions in the placenta
6. Placental vessel morphometry in growth retardation and increased resistance of the umbilical artery Doppler flow
7. Pathologic features of the placenta in women with severe pregnancy complications and thrombophilia
8. Multifunctional roles of thrombin
9. Relevance of markers of hemostasis activation in obstetrics/gynecology and pediatrics
10. Coagulation and fibrinolytic parameters in normal pregnancy and in pregnancy complicated by intrauterine growth retardation
11. The ultrastructure of the arterial supply of the human placenta in pregnancy complicated by fetal growth retardation
12. An ultrastructural study of uteroplacental spiral arteries in hypertensive and normotensive pregnancy and fetal growth retardation
13. Maternal vascular lesions in pre-eclampsia and intrauterine growth retardation: Light microscopy and immunofluorescence
14. Factor VIII related antigen/coagulant activity ratio as a predictor of fetal growth retardation: A comparison with hormone and uric acid measurements
15. Factor VIII complex in normal pregnancy, pre-eclampsia and fetal growth retardation
16. Coagulation and fibrinolysis in pregnancy complicated by intrauterine growth retardation
17. How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review
18. Hyperhomocysteinaemia and protein S deficiency in complicated pregnancies
19. Increased frequency of genetic thrombophilia in women with complications of pregnancy
20. Effects of folic acid and vitamin B6 supplementation on women with hyperhomocysteinemia and a history of preeclampsia or fetal growth restriction
21. Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction
22. Purpura fulminans induced by disseminated intravascular coagulation following infection in 2 unrelated children with double heterozygosity for factor V Leiden and protein S deficiency
23. Lupus anticoagulant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis
24. Risk factors associated with postpartum ovarian vein thrombosis
25. Gene-gene and gene-environment interactions determine risk of thrombosis in families with inherited antithrombin deficiency
26. Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology
27. Homocysteinemia due to folate deficiency
28. Venous thrombosis: A multicausal disease
29. Platelet activation in normotensive and hypertensive pregnancies complicated by intrauterine growth retardation
30. Platelet life span in pregnancies resulting in small-for-gestational age infants
31. Anticoagulant therapy in the prevention of placental infarction and perinatal death
32. Controlled study of subcutaneous heparin and dipyridamole in women at high risk to fetal growth retardation
33. Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: A preliminary study
34. Low-molecular-weight heparin for thrombophilia in pregnant women
35. Low-molecular-weight heparin for the prevention of obstetric complications in women with thrombophilia
36. Thrombophilias and adverse outcomes of pregnancy - What should a clinician do?
37. Inherited thrombophilia in pregnant patients: Detection and treatment paradigm
38. Thrombin-antithrombin III complex levels in normal pregnancy with hypertensive disorders and after delivery
39. The relationship between clinical signs and hypercoagulable state in toxemia of pregnancy
40. Markers of intravascular coagulation and fibrinolysis in preeclampsia: Association with intrauterine growth retardation
41. Hemostatic variables as independent predictors for fetal growth retardation in preeclampsia
42. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia
43. Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension or pre-eclampsia
44. Preeclampsia as chronic disseminated intravascular coagulation. Study of two parameters: Thrombin-antithrombin III complex and D-dimers
45. Plasminogen activators, plasminogen activator inhibitors and markers of intravascular coagulation in pre-eclampsia
46. Blood macrophage colony-stimulating factor and thrombin-antithrombin III complex concentrations in pregnancy and preeclampsia
47. Hemostasis in the uteroplacental and peripheral circulations in normotensive and pre-eclamptic pregnancies
48. Plasma fibrinopeptide A and beta-thromboglobulin in pre-eclampsia and pregnancy hypertension
49. Fibrinogen proteolysis and platelet alpha-granule release in preeclampsia/eclampsia
50. The mechanism of reduced antithrombin III activity in women with preeclampsia
51. Markers for endothelial injury, clotting and platelet activation in preeclampsia
52. Tissue factor levels and high ratio of fibrinopeptide A: D-dimer as a measure of endothelial procoagulant disorder in pre-eclampsia
53. Antiphospholipid antibodies and preeclampsia: A case-control study